DK278088A - Insulinblandindgsktystaller, deres fremstilling og anvendelse - Google Patents

Insulinblandindgsktystaller, deres fremstilling og anvendelse

Info

Publication number
DK278088A
DK278088A DK278088A DK278088A DK278088A DK 278088 A DK278088 A DK 278088A DK 278088 A DK278088 A DK 278088A DK 278088 A DK278088 A DK 278088A DK 278088 A DK278088 A DK 278088A
Authority
DK
Denmark
Prior art keywords
insulin
des
human
mixed crystals
preparation
Prior art date
Application number
DK278088A
Other languages
Danish (da)
English (en)
Other versions
DK278088D0 (da
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK278088D0 publication Critical patent/DK278088D0/da
Publication of DK278088A publication Critical patent/DK278088A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
DK278088A 1987-05-22 1988-05-20 Insulinblandindgsktystaller, deres fremstilling og anvendelse DK278088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873717370 DE3717370A1 (de) 1987-05-22 1987-05-22 Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus

Publications (2)

Publication Number Publication Date
DK278088D0 DK278088D0 (da) 1988-05-20
DK278088A true DK278088A (da) 1988-11-23

Family

ID=6328227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK278088A DK278088A (da) 1987-05-22 1988-05-20 Insulinblandindgsktystaller, deres fremstilling og anvendelse

Country Status (20)

Country Link
US (1) US5028587A (fr)
EP (1) EP0291863B1 (fr)
JP (1) JPS63303930A (fr)
KR (1) KR880013572A (fr)
AT (1) ATE71842T1 (fr)
AU (1) AU601280B2 (fr)
CA (1) CA1335924C (fr)
DE (2) DE3717370A1 (fr)
DK (1) DK278088A (fr)
ES (1) ES2032896T3 (fr)
FI (1) FI93797C (fr)
GR (1) GR3004344T3 (fr)
HU (1) HU203840B (fr)
IE (1) IE60649B1 (fr)
IL (1) IL86452A (fr)
NO (1) NO175641C (fr)
NZ (1) NZ224715A (fr)
PH (1) PH25587A (fr)
PT (1) PT87523B (fr)
ZA (1) ZA883599B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AU9172991A (en) 1990-12-07 1992-07-08 Cnc Development, Inc. Catalytic chemical reactor
SG49239A1 (en) * 1991-05-24 1998-05-18 Amylin Pharmaceuticals Inc Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US6004549A (en) * 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
CN1125081C (zh) 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DK1358209T3 (da) * 2001-02-09 2007-05-07 Genentech Inc Krystallisering af IGF-1
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity
EP2101735A2 (fr) * 2006-11-28 2009-09-23 Marinus Pharmaceuticals, Inc. Formulations de nanoparticules et procédés de préparation et d'utilisation de celles-ci
WO2015084694A2 (fr) 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Procédé de préparation d'insuline cristalline
EP3185887B1 (fr) 2014-08-26 2021-03-10 Merck Sharp & Dohme Corp. Procédé de préparation de compositions d'analogue d'insuline ou d'insuline cristallines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
EG12098A (en) * 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
PT87523B (pt) 1992-09-30
GR3004344T3 (fr) 1993-03-31
DK278088D0 (da) 1988-05-20
PH25587A (en) 1991-08-08
FI93797C (fi) 1995-06-12
HU203840B (en) 1991-10-28
NO175641B (fr) 1994-08-01
EP0291863B1 (fr) 1992-01-22
IL86452A0 (en) 1988-11-15
FI882354A0 (fi) 1988-05-19
NO882207D0 (no) 1988-05-20
NO882207L (no) 1988-11-23
ATE71842T1 (de) 1992-02-15
EP0291863A3 (en) 1990-04-04
FI93797B (fi) 1995-02-28
CA1335924C (fr) 1995-06-13
HUT46546A (en) 1988-11-28
IE881522L (en) 1988-11-22
DE3867903D1 (de) 1992-03-05
PT87523A (pt) 1989-05-31
ZA883599B (en) 1989-01-25
EP0291863A2 (fr) 1988-11-23
IE60649B1 (en) 1994-08-10
NZ224715A (en) 1990-04-26
IL86452A (en) 1993-02-21
AU1648788A (en) 1988-11-24
DE3717370A1 (de) 1988-12-01
ES2032896T3 (es) 1993-03-01
KR880013572A (ko) 1988-12-21
FI882354A (fi) 1988-11-23
NO175641C (no) 1994-11-09
AU601280B2 (en) 1990-09-06
US5028587A (en) 1991-07-02
JPS63303930A (ja) 1988-12-12

Similar Documents

Publication Publication Date Title
DK278088D0 (da) Insulinblandindgsktystaller, deres fremstilling og anvendelse
DK642587D0 (da) Insulinpraeparat
DE3587941T2 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ATE111331T1 (de) Schiene zur behandlung der fraktur von colles.
DK393288D0 (da) Praeparat til saarheling og knogleregenerering
ATE31625T1 (de) Pharmazeutisches mittel zur behandlung des diabetes mellitus.
ZA845620B (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE68908913T2 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
KR900012933A (ko) 당뇨병 및 과혈당증 치료제로 유용한 화합물 및 이의 제조방법
SE8703512D0 (sv) Medel for tandbehandling
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption
NZ236206A (en) Preparation of 2'-methyl-4'-methylenespiro(androstadiene-17,5'(4'h)-oxazol)-3-one derivatives from pregn-5-en-20-ylideneacetamide derivatives by treatment with vilsmeier reagent or acid
SU1840597A1 (ru) Способ получения бис-(хлороксимино)-ацетона
IT1253704B (it) Soluzioni terapeutiche stabili per uso iniettabile a base di fruttosio-1,6-difosfato sale di sodio o di calcio o di magnesio
ES1008313Y (es) Clavo intramedular para el tratamiento de fracturas de huesos largos.

Legal Events

Date Code Title Description
ATS Application withdrawn